Dornase alfa inhalation and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Dornase alfa inhalation and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dornase alfa
Brand name: Pulmozyme
Synonyms: Dornase alfa (inhalation), Dornase Alfa
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dornase alfa inhalation-Moxifloxacin
- Dornase alfa inhalation-Moxifloxacin (Systemic)
- Dornase alfa inhalation-Moxifloxacin Hydrochloride
- Dornase alfa inhalation-Moxifloxacin Injection
- Dornase alfa inhalation-Moxifloxacin Intravenous
- Dornase alfa inhalation-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Dornase alfa Inhalation, oral/nebulization
- Moxetumomab pasudotox-tdfk Intravenous-Doryx
- Moxetumomab pasudotox-tdfk Intravenous-Doryx MPC
- Moxetumomab pasudotox-tdfk Intravenous-Dorzolamide
- Moxetumomab pasudotox-tdfk Intravenous-Dorzolamide and Timolol
- Moxetumomab pasudotox-tdfk Intravenous-Dorzolamide and Timolol Eye Drops